Evidence map›Paper›PMID 35747329›Full record

ArticleInfection and drug resistance2022

Vancomycin Use in Posterior Lumbar Interbody Fusion of Deep Surgical Site Infection.

Shiyong Wang, Rubin Yao, Zhongjie Li, Xiangdong Gong, Jitao Xu, Fajun Yang, Kaishun Yang

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Risk factors for surgical site infections after spinal surgery: a systematic review and meta-analysis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shiyong WangDepartment of Spinal Surgery, First Affiliated Hospital of Dali University, Dali, Yunnan, People's Republic of China.
Rubin YaoDepartment of Spinal Surgery, First Affiliated Hospital of Dali University, Dali, Yunnan, People's Republic of China.
Zhongjie LiDepartment of Spinal Surgery, First Affiliated Hospital of Dali University, Dali, Yunnan, People's Republic of China.
Xiangdong GongDepartment of Spinal Surgery, First Affiliated Hospital of Dali University, Dali, Yunnan, People's Republic of China.
Jitao XuDepartment of Spinal Surgery, First Affiliated Hospital of Dali University, Dali, Yunnan, People's Republic of China.
Fajun YangDepartment of Spinal Surgery, First Affiliated Hospital of Dali University, Dali, Yunnan, People's Republic of China.
Kaishun YangDepartment of Spinal Surgery, First Affiliated Hospital of Dali University, Dali, Yunnan, People's Republic of China.
Dali University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To retrospectively analyze if the use of topical intraoperative vancomycin powder reduces deep surgical site infection (DSSI) after posterior lumbar interbody fusion. Methods: All spinal surgeries for lumbar degenerative disease and underwent posterior fixation interbody fusion between January 2013 and December 2018 were reviewed. A total of 891 patients were included, of which 527 patients (treatment group) received intraoperatively topical vancomycin powder; the others were served as control group. The primary outcomes were the overall incidence of DSSI and the effect of vancomycin on its development. The secondary outcome was risk factors for DSSI. Data on the baseline characteristics, postoperative complications, perioperative risk factors, and one-year postoperative prognoses were extracted from the medical records. Results: A total of 20 patients met the diagnostic criteria for DSSI (2.24%), of which 7 patients (1.33%) in the treatment group and 13 patients (3.57%) in the control group. There was a significant difference in the incidence of DSSI between the groups ( Conclusion: The intraoperative usage of vancomycin powder could reduce effectively decreases the incidence of DSSI after posterior lumbar interbody fusion for degenerative lumbar diseases. High BMI, diabetes mellitus, drinking, and urinary tract infections were independent risk factors for DSSI, whereas the local use of vancomycin protected against these factors.

Indexed as

deep surgical site infectionposterior lumbar interbody fusionrisk factorsvancomycin

Identifiers

PMID35747329
PMCPMC9212791
OpenAlexW4282969962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.